{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T15:28:38Z","timestamp":1794670118967,"version":"4.9.1"},"reference-count":37,"publisher":"American Society of Hematology","issue":"13","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7,8]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Allogeneic hematopoietic stem cell transplantation (HSCT) from HLA-matched donors is the gold standard. However, haploidentical stem cell transplantation using posttransplant cyclophosphamide (PTCY-haplo) and cord blood transplants (CBTs) are alternatives when HLA-matched donors are not available. Using Japanese registry data, we evaluated the impact of haploidentical donor age on posttransplant outcomes by comparing PTCY-haplo and CBT. We analyzed data for 5161 patients aged 16 to 70 years who received their first HSCT for acute leukemia, myelodysplastic syndrome, or chronic myeloid leukemia. Haploidentical donors were categorized as \u201cyounger\u201d (aged &amp;lt;40 years) or \u201colder\u201d (aged \u226540 years), and the patients were divided into younger (aged &amp;lt;50 years) and older (aged \u226550 years) cohorts. In the older cohort, PTCY-haplo from younger donors had better overall survival (OS; 55.5% vs 50.8%, P = .006), lower nonrelapse mortality (NRM; 17.3% vs 28.6%, P &amp;lt; .001), and higher relapse rates (33.0% vs 24.9%, P = .017) than with CBT. PTCY-haplo from older donors had comparable OS (44.1% vs 50.8%, P = 1.00), NRM (27.3% vs 28.6%, P = 1.00), and relapse (29.2% vs 24.9%, P = .90) to that with CBT. In the younger cohort, PTCY-haplo from younger and older donors showed OS, NRM, and relapse comparable with CBT. In the older cohort, cumulative incidence of acute graft-versus-host disease (GVHD) was higher with CBT than with PTCY-haplo, regardless of donor age. However, in the younger cohort, acute GVHD was lower in PTCY-haplo from younger donors than with CBT. PTCY-haplo from younger donors to older patients offers better clinical outcomes than CBT.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2024014938","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T18:27:12Z","timestamp":1741976832000},"page":"3226-3237","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":10,"title":["Impact of haplo-donor age on transplant outcomes: a comparative analysis of haploidentical vs cord blood transplantation"],"prefix":"10.1182","volume":"9","author":[{"given":"Takashi","family":"Nagayama","sequence":"first","affiliation":[{"name":"1Department of Hematology\/Oncology, Kurashiki Central Hospital, Kurashiki, Japan"},{"name":"2Division of Cell Transplantation and Transfusion, Jichi Medical University, Shimotsuke, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-ichiro","family":"Fujiwara","sequence":"additional","affiliation":[{"name":"2Division of Cell Transplantation and Transfusion, Jichi Medical University, Shimotsuke, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Nishiwaki","sequence":"additional","affiliation":[{"name":"3Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiya","family":"Wada","sequence":"additional","affiliation":[{"name":"4Department of Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Uchida","sequence":"additional","affiliation":[{"name":"5Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations, Toranomon Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8814-230X","authenticated-orcid":false,"given":"Masatsugu","family":"Tanaka","sequence":"additional","affiliation":[{"name":"6Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7310-8045","authenticated-orcid":false,"given":"Mamiko","family":"Sakata-Yanagimoto","sequence":"additional","affiliation":[{"name":"7Department of Hematology, University of Tsukuba Hospital, Tsukuba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Onizuka","sequence":"additional","affiliation":[{"name":"8Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3571-700X","authenticated-orcid":false,"given":"Kazuya","family":"Ishiwata","sequence":"additional","affiliation":[{"name":"9Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations, Toranomon Hospital, Kawasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"10Department of Hematology, Hokkaido University Hospital, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3631-244X","authenticated-orcid":false,"given":"Shuichi","family":"Ota","sequence":"additional","affiliation":[{"name":"11Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8661-3179","authenticated-orcid":false,"given":"Noriko","family":"Doki","sequence":"additional","affiliation":[{"name":"12Division of Hematology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4203-990X","authenticated-orcid":false,"given":"Hirohisa","family":"Nakamae","sequence":"additional","affiliation":[{"name":"13Department of Hematology, Osaka Metropolitan University Hospital, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Nishida","sequence":"additional","affiliation":[{"name":"14Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiro","family":"Kawakita","sequence":"additional","affiliation":[{"name":"15Department of Hematology, NHO Kumamoto Medical Center, Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Sawa","sequence":"additional","affiliation":[{"name":"16Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1296-9006","authenticated-orcid":false,"given":"Masahito","family":"Tokunaga","sequence":"additional","affiliation":[{"name":"17Department of Hematology, Imamura General Hospital, Kagoshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7668-6083","authenticated-orcid":false,"given":"Fumihiko","family":"Ishimaru","sequence":"additional","affiliation":[{"name":"18Japanese Red Cross Kanto-Koshinetsu Block Blood Center, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Fukuda","sequence":"additional","affiliation":[{"name":"19Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Kanda","sequence":"additional","affiliation":[{"name":"20Division of Hematology, Jichi Medical University, Shimotsuke, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4404-2870","authenticated-orcid":false,"given":"Yoshiko","family":"Atsuta","sequence":"additional","affiliation":[{"name":"21Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan"},{"name":"22Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5812-9315","authenticated-orcid":false,"given":"Hideki","family":"Nakasone","sequence":"additional","affiliation":[{"name":"23Division of Emerging Medicine for Integrated Therapeutics, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2025,6,27]]},"reference":[{"issue":"3","key":"2025070811065526700_bib1","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1182\/blood.2020007535","article-title":"Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial","volume":"137","author":"Fuchs","year":"2020","journal-title":"Blood"},{"issue":"2","key":"2025070811065526700_bib2","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.bbmt.2019.10.014","article-title":"Prospective randomized study comparing myeloablative unrelated umbilical cord blood transplantation versus HLA-haploidentical related stem cell transplantation for adults with hematologic malignancies","volume":"26","author":"Sanz","year":"2020","journal-title":"Biol Blood Marrow Transpl"},{"issue":"4","key":"2025070811065526700_bib3","doi-asserted-by":"crossref","first-page":"334.e1","DOI":"10.1016\/j.jtct.2021.01.023","article-title":"Single cord blood transplantation versus unmanipulated haploidentical transplantation for adults with acute myeloid leukemia in complete remission","volume":"27","author":"Konuma","year":"2021","journal-title":"Transpl Cell Ther"},{"issue":"6","key":"2025070811065526700_bib4","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/TP.0000000000004006","article-title":"Single cord blood transplantation versus HLA-haploidentical-related donor transplantation using posttransplant cyclophosphamide in patients with hematological malignancies","volume":"106","author":"Wada","year":"2022","journal-title":"Transplantation"},{"issue":"20","key":"2025070811065526700_bib5","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1182\/bloodadvances.2021004462","article-title":"Comparison of haploidentical and umbilical cord blood transplantation after myeloablative conditioning","volume":"5","author":"Wagner","year":"2021","journal-title":"Blood Adv"},{"issue":"1","key":"2025070811065526700_bib6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1182\/bloodadvances.2021004916","article-title":"Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia","volume":"6","author":"Wieduwilt","year":"2022","journal-title":"Blood Adv"},{"issue":"11","key":"2025070811065526700_bib7","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/s41409-022-01770-y","article-title":"Comparable survival outcomes with haploidentical stem cell transplantation and cord blood transplantation","volume":"57","author":"Sugita","year":"2022","journal-title":"Bone Marrow Transpl"},{"issue":"12","key":"2025070811065526700_bib8","doi-asserted-by":"crossref","first-page":"E447","DOI":"10.1002\/ajh.26722","article-title":"Haploidentical transplantation with post-transplant cyclophosphamide versus single cord blood transplantation for myelodysplastic syndrome: a retrospective study from the Adult Myelodysplastic Syndrome Working Group of the Japanese Society for Transplantation and Cellular Therapy (JSTCT)","volume":"97","author":"Konuma","year":"2022","journal-title":"Am J Hematol"},{"issue":"1","key":"2025070811065526700_bib9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41409-019-0499-z","article-title":"The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation","volume":"55","author":"Ciurea","year":"2020","journal-title":"Bone Marrow Transpl"},{"issue":"8","key":"2025070811065526700_bib10","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/s41409-023-01984-8","article-title":"Impact of donor age and relationship on outcomes of peripheral blood haploidentical hematopoietic cell transplantation","volume":"58","author":"Pruitt","year":"2023","journal-title":"Bone Marrow Transpl"},{"issue":"5","key":"2025070811065526700_bib11","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1182\/bloodadvances.2020003922","article-title":"Relationship of donor age and relationship to outcomes of haploidentical transplantation with posttransplant cyclophosphamide","volume":"5","author":"DeZern","year":"2021","journal-title":"Blood Adv"},{"issue":"16","key":"2025070811065526700_bib12","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1182\/bloodadvances.2020001620","article-title":"Impact of donor age and kinship on clinical outcomes after T-cell-replete haploidentical transplantation with PT-Cy","volume":"4","author":"Mariotti","year":"2020","journal-title":"Blood Adv"},{"issue":"3","key":"2025070811065526700_bib13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1182\/bloodadvances.2017014829","article-title":"Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamide","volume":"2","author":"McCurdy","year":"2018","journal-title":"Blood Adv"},{"issue":"2","key":"2025070811065526700_bib14","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/ajh.24963","article-title":"Donor age determines outcome in acute leukemia patients over 40 undergoing haploidentical hematopoietic cell transplantation","volume":"93","author":"Canaani","year":"2018","journal-title":"Am J Hematol"},{"issue":"6","key":"2025070811065526700_bib15","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1182\/blood-2014-03-563130","article-title":"Who is the best donor for a related HLA haplotype-mismatched transplant?","volume":"124","author":"Wang","year":"2014","journal-title":"Blood"},{"issue":"1","key":"2025070811065526700_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12185-015-1894-x","article-title":"Introduction of Transplant Registry Unified Management Program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data)","volume":"103","author":"Atsuta","year":"2016","journal-title":"Int J Hematol"},{"issue":"1","key":"2025070811065526700_bib17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12185-015-1907-9","article-title":"Scripts for TRUMP data analyses. Part II (HLA-related data): statistical analyses specific for hematopoietic stem cell transplantation","volume":"103","author":"Kanda","year":"2016","journal-title":"Int J Hematol"},{"issue":"6","key":"2025070811065526700_bib18","first-page":"825","article-title":"1994 Consensus conference on acute GVHD grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transpl"},{"issue":"2","key":"2025070811065526700_bib19","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","article-title":"Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients","volume":"69","author":"Shulman","year":"1980","journal-title":"Am J Med"},{"issue":"8","key":"2025070811065526700_bib20","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1182\/blood-2014-10-609032","article-title":"Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation","volume":"125","author":"Holtan","year":"2015","journal-title":"Blood"},{"issue":"12","key":"2025070811065526700_bib21","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","article-title":"Defining the intensity of conditioning regimens: working definitions","volume":"15","author":"Bacigalupo","year":"2009","journal-title":"Biol Blood Marrow Transpl"},{"issue":"3","key":"2025070811065526700_bib22","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bbmt.2008.12.497","article-title":"Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the Center for International Blood and Marrow Transplant Research","volume":"15","author":"Giralt","year":"2009","journal-title":"Biol Blood Marrow Transpl"},{"issue":"5","key":"2025070811065526700_bib23","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"issue":"20","key":"2025070811065526700_bib24","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"6","key":"2025070811065526700_bib25","doi-asserted-by":"crossref","first-page":"365.e1","DOI":"10.1016\/j.jtct.2023.03.001","article-title":"Effect of graft-versus-host disease on post-transplantation outcomes following single cord blood transplantation compared with haploidentical transplantation with post-transplantation cyclophosphamide for adult acute myeloid leukemia","volume":"29","author":"Konuma","year":"2023","journal-title":"Transpl Cell Ther"},{"issue":"3","key":"2025070811065526700_bib26","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transpl"},{"issue":"6","key":"2025070811065526700_bib27","doi-asserted-by":"crossref","first-page":"377.e1","DOI":"10.1016\/j.jtct.2023.03.028","article-title":"Impact of donor age in haploidentical-post-transplantation cyclophosphamide versus matched unrelated donor post-transplantation cyclophosphamide hematopoietic stem cell transplantation in patients with acute myeloid leukemia","volume":"29","author":"Mehta","year":"2023","journal-title":"Transpl Cell Ther"},{"issue":"5","key":"2025070811065526700_bib28","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1182\/bloodadvances.2020003922","article-title":"Relationship of donor age and relationship to outcomes of haploidentical transplantation with posttransplant cyclophosphamide","volume":"5","author":"Dezern","year":"2021","journal-title":"Blood Adv"},{"issue":"3","key":"2025070811065526700_bib29","doi-asserted-by":"crossref","first-page":"181.e1","DOI":"10.1016\/j.jtct.2022.12.005","article-title":"Effect of CD34+ cell dose on the outcomes of allogeneic stem cell transplantation with post-transplantation cyclophosphamide","volume":"29","author":"Pedraza","year":"2023","journal-title":"Transpl Cell Ther"},{"issue":"7","key":"2025070811065526700_bib30","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1038\/s41409-021-01219-8","article-title":"Impact of infused CD34+ stem cell dosing for allogeneic peripheral blood stem cell transplantation with post-transplant cyclophosphamide","volume":"56","author":"Elmariah","year":"2021","journal-title":"Bone Marrow Transpl"},{"issue":"2","key":"2025070811065526700_bib31","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.bbmt.2017.10.023","article-title":"Grade II acute graft-versus-host disease and higher nucleated cell graft dose improve progression-free survival after HLA-haploidentical transplant with post-transplant cyclophosphamide","volume":"24","author":"McCurdy","year":"2018","journal-title":"Biol Blood Marrow Transpl"},{"issue":"2","key":"2025070811065526700_bib32","doi-asserted-by":"crossref","first-page":"103.e1","DOI":"10.1016\/j.jtct.2024.11.011","article-title":"Comparison of nonrelapse mortality after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide versus single umbilical cord blood transplantation in hematologic disease","volume":"31","author":"Harada","year":"2025","journal-title":"Transpl Cell Ther"},{"issue":"8","key":"2025070811065526700_bib33","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.bbmt.2013.05.003","article-title":"Clinical factors predicting the response of acute graft-versus-host disease to corticosteroid therapy: an analysis from the GVHD Working Group of the Japan Society for Hematopoietic Cell Transplantation","volume":"19","author":"Murata","year":"2013","journal-title":"Biol Blood Marrow Transpl"},{"issue":"1","key":"2025070811065526700_bib34","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1182\/hematology.2022000327","article-title":"In 2022, which is preferred: haploidentical or cord transplant?","volume":"2022","author":"Nagler","year":"2022","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"2025070811065526700_bib35","unstructured":"Japanese Data Center for Hematopoietic Cell Transplantation\n          . Hematopoietic cell transplantation in Japan annual report of nationwide survey 2020 summary slide. Accessed 26 January 2025. https:\/\/www.jdchct.or.jp\/en\/data\/slide\/2020\/."},{"issue":"8","key":"2025070811065526700_bib36","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/s41409-019-0476-6","article-title":"Worldwide Network for Blood & Marrow Transplantation (WBMT) special article, challenges facing emerging alternate donor registries","volume":"54","author":"Aljurf","year":"2019","journal-title":"Bone Marrow Transpl"},{"key":"2025070811065526700_bib37","author":"Japanese Society for Transplantation and Cellular Therapy","year":"2023","edition":"3rd ed"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/13\/3226\/2382576\/blooda_adv-2024-014938-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/13\/3226\/2382576\/blooda_adv-2024-014938-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T11:07:17Z","timestamp":1751972837000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/9\/13\/3226\/536043\/Impact-of-haplo-donor-age-on-transplant-outcomes-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":37,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2025,7,8]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2024014938","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7,8]]},"published":{"date-parts":[[2025,6,27]]}}}